The importance of medical device labeling has increased significantly since PRISYM ID developed its first URS for a validatable enterprise labeling solution with a major global medical device manufacturer (and long-standing client) in 1999.
However many within the industry still remain unsure of regional regulations around the quality requirements for medical device label inspection, such as the FDA’s UDI, the EU’s MDR and FDA 21 CFR part 11.
A broader view of the labeling procedures is essential. In the battle to deliver safe, accurate and compliant product information, it’s not just about the quality of the medical device label – it’s also about the data. By implementing a lifecycle medical device label software supported with up to date validation documentation based on the GAMP 5 Model, you can ensure peace of mind.
The size of the organization does not matter — the FDA and other regulatory bodies do not draw distinctions - so SME organizations also have to take a strategic approach to the management of their data and that is where we can help with our scalable and validatable medical device labeling software solutions.
Through their NEW Lifetime Partnership Program, Prysim ID offers lifelong support on a flexible basis; working together to achieve the vision, objectives and requirements that underpin your labeling strategy as you grow.